AUB ScholarWorks

Effect of endotoxin challenge on normal, tumor initiated, and invasive human breast cells -

Show simple item record

dc.contributor.author Yassine, Farah Aly,
dc.date.accessioned 2017-08-30T14:27:25Z
dc.date.available 2017-08-30T14:27:25Z
dc.date.issued 2016
dc.date.submitted 2016
dc.identifier.other b19016542
dc.identifier.uri http://hdl.handle.net/10938/11024
dc.description Thesis. M.S. American University of Beirut. Department of Biology, 2016. T:6498
dc.description Advisor : Dr. Rabih Talhouk, Professor, Biology ; Committee members : Dr. Marwan El-Sabban, Professor, Anatomy, Cell Biology and Physiological Sciences ; Dr. Hala Gali-Muhtasib, Professor, Biology.
dc.description Includes bibliographical references (leaves 84-106)
dc.description.abstract Breast cancer is the most common female cancer worldwide, recording high incidence rates caused by risk factors associated with urbanization and economic development. Inflammatory breast cancer (IBC) is the most lethal type of breast cancer, targeting young women, mainly after chronic inflammation. Interestingly, endotoxin (ET) is known to simulate inflammation-like conditions in several in vitro and in vivo models including mammary epithelial cells; however, little is known about the effect of ET-induced inflammation on breast cancer initiation events. In order to investigate the tumor initiating role of ET-induced inflammation, we monitored inflammatory mediators’ response and cancer progression events of in vitro 2D cultures of normal mouse mammary epithelial cells (SCp2), 2D and 3D breast progression models of both, non-tumorigenic S1 cells, and intermediate stage of tumorigenesis S1-Connexin 43 knockouts (Cx43-KO S1), that can closely mimic the in vivo mammary epithelial morphology. Moderately invasive MCF-7 and highly invasive MDA-MB-231 human breast cancer cells were exploited in order to determine the effect of ET treatment on tumor invasion events. Short-term treatment (48 hours) of SCp2 cells with ET concentrations ranging from 0.1 to 1 µg-ml upregulated the levels of MMP-9 produced by SCp2 cells in a dose-dependent manner. Long-term ET treatment (one month), but not short-term, enhanced the migration of SCp2 cells in wound healing assays. As for 2D cultures of the human S1 cells, 9-day ET treatment with concentrations ranging from 2 to 20 µg-ml upregulated the levels of MMP-9 in the conditioned media in a dose dependent manner. MMP-9 production by S1 cells was also upregulated upon long-term ET treatment (one month) with 10 µg-ml. Interestingly, the rate of S1 cells invasion though matrigel substrata was enhanced by both, 9-day and long-term treatment with 10 µg-ml ET. Moreover, immunofluorescent imaging of S1 acini in 3D cultures suggested lumen disruption and β-
dc.format.extent 1 online resource (xviii, 106 leaves) : illustrations (some color)
dc.language.iso eng
dc.relation.ispartof Theses, Dissertations, and Projects
dc.subject.classification T:006498
dc.subject.lcsh Cancer cells.
dc.subject.lcsh Breast -- Cancer.
dc.subject.lcsh Inflammation.
dc.subject.lcsh Endotoxins.
dc.subject.lcsh Epithelial cells.
dc.subject.lcsh Gap junctions (Cell biology)
dc.title Effect of endotoxin challenge on normal, tumor initiated, and invasive human breast cells -
dc.type Thesis
dc.contributor.department Faculty of Arts and Sciences.
dc.contributor.department Department of Biology,
dc.contributor.institution American University of Beirut.


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account